| 生物活性 | |||
|---|---|---|---|
| 描述 | PKSI-527, a novel and highly selective inhibitor of plasma kallikrein, can mitigate collagen-induced arthritis (CIA) through alterations in the kallikrein-kinin system[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.11mL 0.42mL 0.21mL | 10.55mL 2.11mL 1.05mL | 21.10mL 4.22mL 2.11mL | 
| 参考文献 | 
|---|